Clinical Trials on Refractory Benign Strictures

Total 4466 results

NeoTract, Inc.

Completed

The Safety and Effectiveness of UroLift: LIFT Pivotal Study (LIFT)

Benign Prostatic Hyperplasia

United States, Australia, Canada
IRCCS San Raffaele

Unknown

Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands (ExpHo)

Benign Prostatic Hyperplasia

Italy
JW Pharmaceutical

Completed

Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System (CV)

Benign Prostatic Hyperplasia

Korea, Republic of
NeoTract, Inc.

Completed

BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia (BPH-6)

Benign Prostatic Hyperplasia

Denmark, United Kingdom, Germany
PROCEPT BioRobotics

Completed

AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia (ABS)

Benign Prostatic Hyperplasia

India
University of Alberta
Merck Frosst Canada Ltd.

Withdrawn

On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)

Benign Prostatic Hyperplasia

Canada
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients

Benign Prostatic Hyperplasia

Korea, Republic of
Eli Lilly and Company
Nippon Shinyaku Co., Ltd.

Completed

A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).

Benign Prostatic Hyperplasia

Japan
Beni-Suef University

Completed

Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.

Benign Prostatic Hyperplasia

Egypt
Assiut University

Unknown

Does Simethicone Improve Operative Field in Gynecological Operations

Benign Gynecologic Neoplasm

Egypt
Shiraz University of Medical Sciences

Completed

Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate (TURP)

Benign Prostate Hyperplasia

Iran, Islamic Republic of
University Hospital, Rouen

Terminated

Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment. (Prost-EMBOL)

Benign Prostatic Hyperplasia

France
Assistance Publique - Hôpitaux de Paris

Completed

QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser) (QUAPELLA)

Benign Prostatic Hyperplasia

France
Nymox Corporation

Completed

Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Diskapi Yildirim Beyazit Education and Research...

Unknown

Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy. (TURP)

Benign Prostate Hyperplasia

Turkey
Diskapi Teaching and Research Hospital

Completed

Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration

Benign Prostate Hyperplasia

Turkey
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United Kingdom, Taiwan, Korea, Republic of, Canada, Slovakia, France, Italy, Austria, Czech Republic, Australia, Germany
QLT Inc.

Completed

Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Canada
Samsung Medical Center

Unknown

Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia
Eli Lilly and Company

Completed

Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men

Benign Prostatic Hyperplasia

Korea, Republic of
Sanofi

Completed

Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH

Benign Prostatic Hyperplasia

Japan
Assistance Publique - Hôpitaux de Paris

Completed

Procedure Transurethral Needle Ablation (TUNA) and Hospitalization of Short Duration (EPURE)

Benign Prostatic Hyperplasia

France
Eli Lilly and Company
ICOS Corporation

Completed

Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Greece, Portugal
RECORDATI GROUP

Completed

Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH

Benign Prostatic Hyperplasia

United Kingdom
Weill Medical College of Cornell University

Completed

A Prospective Evaluation of the GreenLight Model 120 Laser

Benign Prostatic Hyperplasia

United States
Hospices Civils de Lyon

Unknown

Kinetics of the Finasteride Prostate Induced Apoptosis

Benign Prostatic Hyperplasia

France
Rijnstate Hospital

Completed

Bone Mineral Density Changes of the Acetabulum After Revision Hip Arthroplasty Using Bone Impaction Grafting (BMD&BIG)

Disorder of Bone Density and Structure, Unspecified | Satisfaction

Netherlands
National Cancer Institute (NCI)

Active, not recruiting

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Malignant Solid Neoplasm | Recurrent Medulloblastoma | Recurrent... and other conditions

United States, Puerto Rico
University of Medicine and Pharmacy Craiova
Tel-Aviv Sourasky Medical Center; Shengjing Hospital; Institut Paoli-Calmettes; University of Santiago de Compostela and other collaborators

Completed

Clinical Impact of EUS Elastography Mean Strain Histograms (SH) and Contrast Peak-enhancement in Focal Pancreatic Masses and Lymph Nodes (ADVEUS)

Pancreatic Cancer | Secondary Malignant Neoplasm of Lymph Node | Benign Neoplasm of Lymph Nodes | Benign Pancreatic Tumors

Romania
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia in Remission | Adult Acute Lymphoblastic Leukemia in Remission | Refractory Anemia With Excess Blasts | Refractory... and other conditions

United States
Sumithira Vasu
National Cancer Institute (NCI)

Recruiting

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent High Grade... and other conditions

United States
Fred Hutchinson Cancer Center
Incyte Corporation

Terminated

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Refractory Soft Tissue Sarcoma | Metastatic Leiomyosarcoma | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Advanced Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Advanced Synovial Sarcoma | Metastatic Chondrosarcoma | Advanced Leiomyosarcoma | Metastatic Myxoid... and other conditions

United States
Jonsson Comprehensive Cancer Center
U.S. Army Medical Research and Development Command; U.S. Army Medical Research...

Completed

MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer

Breast Carcinoma | Malignant Breast Neoplasm | Benign Breast Neoplasm

United States
PROCEPT BioRobotics

Completed

Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II (AHA II)

Benign Prostatic Hyperplasia

India
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Recruiting

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Refractory Mixed Phenotype Acute Leukemia | Refractory Acute Leukemia... and other conditions

United States
Nkarta Inc.

Active, not recruiting

NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

MDS | AML, Adult | Relapsed/Refractory AML | Refractory Myelodysplastic Syndromes

United States
The Lymphoma Academic Research Organisation
Lymphoma Study Association

Not yet recruiting

Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

Refractory High Grade B-Cell Lymphoma | Diffuse Large B-cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Lymphoma

France
University of Utah
Ohio State University

Active, not recruiting

Refinement of Suicide Risk Management Intervention

Structured Interview | Narrative Assessment | Safety Plan | Crisis Response Plan

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome

Severe Aplastic Anemia (SAA) | Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)

United States
Astex Pharmaceuticals, Inc.

Withdrawn

Study of SGI-1776, a PIM Kinase Inhibitor, in Subjects With Relapsed/Refractory Leukemias

Relapsed/Refractory Leukemias

United States
PharmaMar

Terminated

Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia

Relapsed/Refractory Leukemia

United States
The Affiliated Hospital of the Chinese Academy...
Chinese PLA General Hospital

Unknown

Allogeneic CART-33 for Relapsed/Refractory CD33+ AML

Relapsed and/or Refractory CD33+ AML

China
Paratek Pharmaceuticals Inc

Completed

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Bacterial Infections | Skin Structures and Soft Tissue Infections

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Active, not recruiting

A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)

Glucocorticoid-Refractory aGVHD

China
St. Jude Children's Research Hospital

Completed

Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia

Leukemia | Refractory Solid Tumors

United States
Changhai Hospital

Unknown

Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures

Cholangiocarcinoma

China, Slovakia
Postgraduate Institute of Medical Education and...

Unknown

Midodrine and Albumin in Patients With Refractory Ascites

Refractory Ascites
NovaShunt AG

Completed

A Feasibility Study of the Automated Fluid Shunt (AFS) for Automated Ascites Removal

Refractory Ascites

Czech Republic
Dr. med. Gautier Müllhaupt

Recruiting

Aquablation vs. Holmium Laser Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia in Medium to Large Size Prostates (ATHLETE)

Benign Prostatic Hyperplasia (BPH)

Switzerland
Assiut University

Completed

HoLEP in Management of BPH Patients With Predominant Voiding vs Storage LUTS: A Comparative Retrospective Study

Benign Prostatic Hyperplasia (BPH)

Egypt

Clinical Trials on Refractory Benign Strictures

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations